Cortifoam Alternatives Compared
Cortifoam | Budesonide | Mesalamine |
|
---|
Cortifoam (hydrocortisone) | Budesonide | Mesalamine |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Inflammatory Bowel Disease, Ulcerative Proctitis. Cortifoam may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Crohn's Disease, Asthma - Maintenance, Asthma, Autoimmune Hepatitis, Crohn's Disease - Maintenance, Inflammatory Bowel Disease, Ulcerative Colitis - Active, Ulcerative Colitis, Primary... View more |
Prescription only
Prescribed for Crohn's Disease - Maintenance, Inflammatory Bowel Disease, Ulcerative Colitis - Active, Ulcerative Colitis - Maintenance, Ulcerative Colitis, Ulcerative Proctitis, Crohn's Disease... View more |
Related suggestions Inflammatory Bowel Disease
|
|||||||||||||||||||||||
More about Cortifoam (hydrocortisone) | More about Budesonide | More about Mesalamine | ||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Be the first to share your experience with this drug. |
Budesonide has an average rating of 6.5 out of 10 from a total of 141 ratings on Drugs.com. 54% of reviewers reported a positive effect, while 25% reported a negative effect. |
Mesalamine has an average rating of 7.1 out of 10 from a total of 425 ratings on Drugs.com. 63% of reviewers reported a positive effect, while 20% reported a negative effect. |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Side Effects | ||||||||||||||||||||||||||
See also: Cortifoam side effects in more detail. |
See also: budesonide side effects in more detail. |
See also: mesalamine side effects in more detail. |
||||||||||||||||||||||||
Generic Availability | ||||||||||||||||||||||||||
Lower cost generic |
Lower cost generic |
|||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Cortifoam prices |
View all budesonide prices |
View all mesalamine prices |
||||||||||||||||||||||||
Dosage Form(s) Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
Other hydrocortisone brands include: Alkindi Sprinkle, Cortef, Cortenema, Solu-Cortef | Entocort EC, Eohilia, Pulmicort Flexhaler, Pulmicort Respules, Tarpeyo, Uceris | Apriso, Asacol, Asacol HD, Canasa, Canasa Pac, Delzicol, Lialda, Pentasa, Rowasa, Rowasa Sulfite Free, Zaldyon View more | ||||||||||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
12 hours |
2.8 hours |
10 hours |
||||||||||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category B
No proven risk in humans
Excluding Asacol And Asacol HD
Category C
Risk cannot be ruled out
Asacol And Asacol HD See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 600 drugs are known to interact with Cortifoam:
|
A total of 511 drugs are known to interact with budesonide:
|
A total of 120 drugs are known to interact with mesalamine:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
N/A |
October 02, 2001 |
December 24, 1987 |
||||||||||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
N/A |
||||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient resources | ||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
N/A |
||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
|
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.